-
1
-
-
33847125372
-
Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat
-
Abdul-Monim Z., Neill J.C., Reynolds G.P. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat. J Psychopharmacol 2007, 21:198-205.
-
(2007)
J Psychopharmacol
, vol.21
, pp. 198-205
-
-
Abdul-Monim, Z.1
Neill, J.C.2
Reynolds, G.P.3
-
2
-
-
12244296144
-
The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat
-
Abdul-Monim Z., Reynolds G.P., Neill J.C. The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat. J Psychopharmacol 2003, 17:57-65.
-
(2003)
J Psychopharmacol
, vol.17
, pp. 57-65
-
-
Abdul-Monim, Z.1
Reynolds, G.P.2
Neill, J.C.3
-
3
-
-
33645056175
-
The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm
-
Abdul-Monim Z., Reynolds G.P., Neill J.C. The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm. Behav Brain Res 2006, 169:263-273.
-
(2006)
Behav Brain Res
, vol.169
, pp. 263-273
-
-
Abdul-Monim, Z.1
Reynolds, G.P.2
Neill, J.C.3
-
4
-
-
0035970691
-
Neurocognitive and social functioning in schizophrenia and other diagnoses
-
Addington J., Addington D., Gasbarre L. Neurocognitive and social functioning in schizophrenia and other diagnoses. Schizophr Res 2001, 48:367-368.
-
(2001)
Schizophr Res
, vol.48
, pp. 367-368
-
-
Addington, J.1
Addington, D.2
Gasbarre, L.3
-
5
-
-
0034055690
-
Serotonin model of schizophrenia: emerging role of glutamate mechanisms
-
Aghajanian G.K., Marek G.J. Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Brain Res Rev 2000, 31:302-312.
-
(2000)
Brain Res Brain Res Rev
, vol.31
, pp. 302-312
-
-
Aghajanian, G.K.1
Marek, G.J.2
-
6
-
-
34347204172
-
Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex
-
Amargos-Bosch M., Adell A., Artigas F. Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex. J Neurochem 2007, 102:550-561.
-
(2007)
J Neurochem
, vol.102
, pp. 550-561
-
-
Amargos-Bosch, M.1
Adell, A.2
Artigas, F.3
-
7
-
-
0034054949
-
Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-d-aspartate receptor antagonists
-
Anand A., Charney D.S., Oren D.A., Berman R.M., Hu X.S., Cappiello A., et al. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-d-aspartate receptor antagonists. Arch Gen Psychiatry 2000, 57:270-276.
-
(2000)
Arch Gen Psychiatry
, vol.57
, pp. 270-276
-
-
Anand, A.1
Charney, D.S.2
Oren, D.A.3
Berman, R.M.4
Hu, X.S.5
Cappiello, A.6
-
8
-
-
0036268294
-
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder
-
Bilder R.M., Goldman R.S., Volavka J., Czobor P., Hoptman M., Sheitman B., et al. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 2002, 159:1018-1028.
-
(2002)
Am J Psychiatry
, vol.159
, pp. 1018-1028
-
-
Bilder, R.M.1
Goldman, R.S.2
Volavka, J.3
Czobor, P.4
Hoptman, M.5
Sheitman, B.6
-
9
-
-
0035280269
-
Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study
-
Cuesta M.J., Peralta V., Zarzuela A. Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Schizophr Res 2001, 48:17-28.
-
(2001)
Schizophr Res
, vol.48
, pp. 17-28
-
-
Cuesta, M.J.1
Peralta, V.2
Zarzuela, A.3
-
10
-
-
33947121649
-
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia
-
Depoortere R., Bardin L., Auclair A.L., Kleven M.S., Prinssen E., Colpaert F., et al. F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia. Br J Pharmacol 2007, 151:253-265.
-
(2007)
Br J Pharmacol
, vol.151
, pp. 253-265
-
-
Depoortere, R.1
Bardin, L.2
Auclair, A.L.3
Kleven, M.S.4
Prinssen, E.5
Colpaert, F.6
-
11
-
-
34347369304
-
Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics
-
Didriksen M., Skarsfeldt T., Arnt J. Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics. Psychopharmacology (Berlin) 2007, 193:225-233.
-
(2007)
Psychopharmacology (Berlin)
, vol.193
, pp. 225-233
-
-
Didriksen, M.1
Skarsfeldt, T.2
Arnt, J.3
-
12
-
-
0038402678
-
Insight and neurocognition in schizophrenia
-
Drake R.J., Lewis S.W. Insight and neurocognition in schizophrenia. Schizophr Res 2003, 62:165-173.
-
(2003)
Schizophr Res
, vol.62
, pp. 165-173
-
-
Drake, R.J.1
Lewis, S.W.2
-
13
-
-
24344443707
-
Long-term course of adolescent schizophrenia
-
Fleischhaker C., Schulz E., Tepper K., Martin M., Hennighausen K., Remschmidt H. Long-term course of adolescent schizophrenia. Schizophr Bull 2005, 31:769-780.
-
(2005)
Schizophr Bull
, vol.31
, pp. 769-780
-
-
Fleischhaker, C.1
Schulz, E.2
Tepper, K.3
Martin, M.4
Hennighausen, K.5
Remschmidt, H.6
-
14
-
-
72649097579
-
Asenapine improves cognitive function in acute schizophrenia: a placebo- and risperidone-controlled trial
-
Fleming K., Potkin S.G., Binneman B., Keller D.S., Alphs L., Panagides J. Asenapine improves cognitive function in acute schizophrenia: a placebo- and risperidone-controlled trial. Presented at: 160th Annual Meeting of the American Psychiatric Association 2007.
-
(2007)
Presented at: 160th Annual Meeting of the American Psychiatric Association
-
-
Fleming, K.1
Potkin, S.G.2
Binneman, B.3
Keller, D.S.4
Alphs, L.5
Panagides, J.6
-
15
-
-
38849164363
-
Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia
-
Franberg O., Wiker C., Marcus M.M., Konradsson A., Jardemark K., Schilstrom B., et al. Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia. Psychopharmacology (Berlin) 2008, 196:417-429.
-
(2008)
Psychopharmacology (Berlin)
, vol.196
, pp. 417-429
-
-
Franberg, O.1
Wiker, C.2
Marcus, M.M.3
Konradsson, A.4
Jardemark, K.5
Schilstrom, B.6
-
17
-
-
34548348729
-
Molecular targets for treating cognitive dysfunction in schizophrenia
-
Gray J.A., Roth B.L. Molecular targets for treating cognitive dysfunction in schizophrenia. Schizophr Bull 2007, 33:1100-1119.
-
(2007)
Schizophr Bull
, vol.33
, pp. 1100-1119
-
-
Gray, J.A.1
Roth, B.L.2
-
18
-
-
34548621479
-
Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat
-
Grayson B., Idris N.F., Neill J.C. Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat. Behav Brain Res 2007, 184:31-38.
-
(2007)
Behav Brain Res
, vol.184
, pp. 31-38
-
-
Grayson, B.1
Idris, N.F.2
Neill, J.C.3
-
19
-
-
0029918481
-
What are the functional consequences of neurocognitive deficits in schizophrenia?
-
Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry 1996, 153:321-330.
-
(1996)
Am J Psychiatry
, vol.153
, pp. 321-330
-
-
Green, M.F.1
-
20
-
-
33747329318
-
Pharmacological approaches to the management of cognitive dysfunction in schizophrenia
-
Harvey P.D., McClure M.M. Pharmacological approaches to the management of cognitive dysfunction in schizophrenia. Drugs 2006, 66:1465-1473.
-
(2006)
Drugs
, vol.66
, pp. 1465-1473
-
-
Harvey, P.D.1
McClure, M.M.2
-
21
-
-
26444461639
-
5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats
-
Hatcher P.D., Brown V.J., Tait D.S., Bate S., Overend P., Hagan J.J., et al. 5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats. Psychopharmacology (Berlin) 2005, 181:253-259.
-
(2005)
Psychopharmacology (Berlin)
, vol.181
, pp. 253-259
-
-
Hatcher, P.D.1
Brown, V.J.2
Tait, D.S.3
Bate, S.4
Overend, P.5
Hagan, J.J.6
-
22
-
-
33751162382
-
SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models
-
Hirst W.D., Stean T.O., Rogers D.C., Sunter D., Pugh P., Moss S.F., et al. SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models. Eur J Pharmacol 2006, 553:109-119.
-
(2006)
Eur J Pharmacol
, vol.553
, pp. 109-119
-
-
Hirst, W.D.1
Stean, T.O.2
Rogers, D.C.3
Sunter, D.4
Pugh, P.5
Moss, S.F.6
-
23
-
-
53949102049
-
Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus
-
Huang M., Li Z., Dai J., Shahid M., Wong E.H., Meltzer H.Y. Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus. Neuropsychopharmacology 2008, 33:2934-2945.
-
(2008)
Neuropsychopharmacology
, vol.33
, pp. 2934-2945
-
-
Huang, M.1
Li, Z.2
Dai, J.3
Shahid, M.4
Wong, E.H.5
Meltzer, H.Y.6
-
24
-
-
72649104250
-
Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms
-
Idris N., Neill J., Grayson B., Bang-Andersen B., Witten L.M., Brennum L.T., et al. Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms. Psychopharmacology (Berlin) 2010, 208:23-36.
-
(2010)
Psychopharmacology (Berlin)
, vol.208
, pp. 23-36
-
-
Idris, N.1
Neill, J.2
Grayson, B.3
Bang-Andersen, B.4
Witten, L.M.5
Brennum, L.T.6
-
25
-
-
26444535836
-
Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and d-amphetamine in the rat
-
Idris N.F., Repeto P., Neill J.C., Large C.H. Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and d-amphetamine in the rat. Psychopharmacology (Berlin) 2005, 179:336-348.
-
(2005)
Psychopharmacology (Berlin)
, vol.179
, pp. 336-348
-
-
Idris, N.F.1
Repeto, P.2
Neill, J.C.3
Large, C.H.4
-
26
-
-
0030862672
-
Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine
-
Jentsch J.D., Redmond D.E., Elsworth J.D., Taylor J.R., Youngren K.D., Roth R.H. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science 1997, 277:953-955.
-
(1997)
Science
, vol.277
, pp. 953-955
-
-
Jentsch, J.D.1
Redmond, D.E.2
Elsworth, J.D.3
Taylor, J.R.4
Youngren, K.D.5
Roth, R.H.6
-
27
-
-
0032903301
-
The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia
-
Jentsch J.D., Roth R.H. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1999, 20:201-225.
-
(1999)
Neuropsychopharmacology
, vol.20
, pp. 201-225
-
-
Jentsch, J.D.1
Roth, R.H.2
-
28
-
-
0035205333
-
Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats
-
Jentsch J.D., Taylor J.R. Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats. Neuropsychopharmacology 2001, 24:66-74.
-
(2001)
Neuropsychopharmacology
, vol.24
, pp. 66-74
-
-
Jentsch, J.D.1
Taylor, J.R.2
-
29
-
-
0030851961
-
Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat
-
Jentsch J.D., Tran A., Le D., Youngren K.D., Roth R.H. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology 1997, 17:92-99.
-
(1997)
Neuropsychopharmacology
, vol.17
, pp. 92-99
-
-
Jentsch, J.D.1
Tran, A.2
Le, D.3
Youngren, K.D.4
Roth, R.H.5
-
30
-
-
0025907854
-
Behavioural rigidity and rule-learning deficits following isolation-rearing in the rat: neurochemical correlates
-
Jones G.H., Marsden C.A., Robbins T.W. Behavioural rigidity and rule-learning deficits following isolation-rearing in the rat: neurochemical correlates. Behav Brain Res 1991, 43:35-50.
-
(1991)
Behav Brain Res
, vol.43
, pp. 35-50
-
-
Jones, G.H.1
Marsden, C.A.2
Robbins, T.W.3
-
31
-
-
0037405871
-
Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy
-
Kapur S., VanderSpek S.C., Brownlee B.A., Nobrega J.N. Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy. J Pharmacol Exp Ther 2003, 305:625-631.
-
(2003)
J Pharmacol Exp Ther
, vol.305
, pp. 625-631
-
-
Kapur, S.1
VanderSpek, S.C.2
Brownlee, B.A.3
Nobrega, J.N.4
-
32
-
-
34247643916
-
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial
-
Keefe R.S., Bilder R.M., Davis S.M., Harvey P.D., Palmer B.W., Gold J.M., et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry 2007, 64:633-647.
-
(2007)
Arch Gen Psychiatry
, vol.64
, pp. 633-647
-
-
Keefe, R.S.1
Bilder, R.M.2
Davis, S.M.3
Harvey, P.D.4
Palmer, B.W.5
Gold, J.M.6
-
33
-
-
0142095005
-
NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development
-
Krystal J.H., D'Souza D.C., Mathalon D., Perry E., Belger A., Hoffman R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berlin) 2003, 169:215-233.
-
(2003)
Psychopharmacology (Berlin)
, vol.169
, pp. 215-233
-
-
Krystal, J.H.1
D'Souza, D.C.2
Mathalon, D.3
Perry, E.4
Belger, A.5
Hoffman, R.6
-
34
-
-
2342614121
-
Should cognitive deficit be a diagnostic criterion for schizophrenia?
-
Lewis R. Should cognitive deficit be a diagnostic criterion for schizophrenia?. J Psychiatry Neurosci 2004, 29:102-113.
-
(2004)
J Psychiatry Neurosci
, vol.29
, pp. 102-113
-
-
Lewis, R.1
-
36
-
-
70349652500
-
Asenapine effects in animal models of psychosis and cognitive function
-
Marston H.M., Young J.W., Martin F.D., Serpa K.A., Moore C.L., Wong E.H., et al. Asenapine effects in animal models of psychosis and cognitive function. Psychopharmacology (Berlin) 2009, 206:699-714.
-
(2009)
Psychopharmacology (Berlin)
, vol.206
, pp. 699-714
-
-
Marston, H.M.1
Young, J.W.2
Martin, F.D.3
Serpa, K.A.4
Moore, C.L.5
Wong, E.H.6
-
37
-
-
0032517108
-
Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats
-
Martin P., Carlsson M.L., Hjorth S. Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats. Neuroreport 1998, 9:2985-2988.
-
(1998)
Neuroreport
, vol.9
, pp. 2985-2988
-
-
Martin, P.1
Carlsson, M.L.2
Hjorth, S.3
-
39
-
-
40849097398
-
A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats
-
McLean S.L., Beck J.P., Woolley M.L., Neill J.C. A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats. Behav Brain Res 2008, 189:152-158.
-
(2008)
Behav Brain Res
, vol.189
, pp. 152-158
-
-
McLean, S.L.1
Beck, J.P.2
Woolley, M.L.3
Neill, J.C.4
-
40
-
-
70349575345
-
Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat
-
McLean S.L., Idris N.F., Woolley M.L., Thomas D., Neill J.C. Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat. Psychopharmacology 2009, 206(3):403-414.
-
(2009)
Psychopharmacology
, vol.206
, Issue.3
, pp. 403-414
-
-
McLean, S.L.1
Idris, N.F.2
Woolley, M.L.3
Thomas, D.4
Neill, J.C.5
-
41
-
-
65049085795
-
D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia
-
McLean S.L., Idris N.F., Woolley M.L., Neill J.C. D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia. Eur Neuropsychopharmacol 2009, 19:440-450.
-
(2009)
Eur Neuropsychopharmacol
, vol.19
, pp. 440-450
-
-
McLean, S.L.1
Idris, N.F.2
Woolley, M.L.3
Neill, J.C.4
-
42
-
-
65049088927
-
6 antagonists improve a subchronic phencyclidine-induced reversal learning deficit in rats
-
6 antagonists improve a subchronic phencyclidine-induced reversal learning deficit in rats. Schizophr Res 2008, 102:60.
-
(2008)
Schizophr Res
, vol.102
, pp. 60
-
-
Neill, J.C.1
Idris, N.F.2
Arnt, J.3
-
43
-
-
34548255299
-
Executive function in schizophrenia: what impact do antipsychotics have?
-
O'Grada C., Dinan T. Executive function in schizophrenia: what impact do antipsychotics have?. Hum Psychopharmacol 2007, 22:397-406.
-
(2007)
Hum Psychopharmacol
, vol.22
, pp. 397-406
-
-
O'Grada, C.1
Dinan, T.2
-
45
-
-
35948982974
-
Efficacy and tolerability of asenapine in acute schizophrenia: a placebo- and risperidone-controlled trial
-
Potkin S.G., Cohen M., Panagides J. Efficacy and tolerability of asenapine in acute schizophrenia: a placebo- and risperidone-controlled trial. J Clin Psychiatry 2007, 68:1492-1500.
-
(2007)
J Clin Psychiatry
, vol.68
, pp. 1492-1500
-
-
Potkin, S.G.1
Cohen, M.2
Panagides, J.3
-
46
-
-
0028989815
-
The role of 5-HT2A receptors in antipsychotic activity
-
Schmidt C.J., Sorensen S.M., Kehne J.H., Carr A.A., Palfreyman M.G. The role of 5-HT2A receptors in antipsychotic activity. Life Sci 1995, 56:2209-2222.
-
(1995)
Life Sci
, vol.56
, pp. 2209-2222
-
-
Schmidt, C.J.1
Sorensen, S.M.2
Kehne, J.H.3
Carr, A.A.4
Palfreyman, M.G.5
-
47
-
-
0029930927
-
Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding
-
Schotte A., Janssen P.F., Gommeren W., Luyten W.H., Van Gompel P., Lesage A.S., et al. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berlin) 1996, 124:57-73.
-
(1996)
Psychopharmacology (Berlin)
, vol.124
, pp. 57-73
-
-
Schotte, A.1
Janssen, P.F.2
Gommeren, W.3
Luyten, W.H.4
Van Gompel, P.5
Lesage, A.S.6
-
48
-
-
58649100010
-
Asenapine: a novel psychopharmacologic agent with a unique human receptor signature
-
Shahid M., Walker G., Zorn S., Wong E. Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. J Psychopharmacol 2009, 23:65-73.
-
(2009)
J Psychopharmacol
, vol.23
, pp. 65-73
-
-
Shahid, M.1
Walker, G.2
Zorn, S.3
Wong, E.4
-
49
-
-
0032588207
-
The dopamine D3/D2 receptor agonist 7-OH-DPAT induces cognitive impairment in the marmoset
-
Smith A.G., Neill J.C., Costall B. The dopamine D3/D2 receptor agonist 7-OH-DPAT induces cognitive impairment in the marmoset. Pharmacol Biochem Behav 1999, 63:201-211.
-
(1999)
Pharmacol Biochem Behav
, vol.63
, pp. 201-211
-
-
Smith, A.G.1
Neill, J.C.2
Costall, B.3
-
50
-
-
38049057135
-
Efficacy of antipsychotics to reverse phencyclidine-induced social interaction deficits in female rats-a preliminary investigation
-
Snigdha S., Neill J.C. Efficacy of antipsychotics to reverse phencyclidine-induced social interaction deficits in female rats-a preliminary investigation. Behav Brain Res 2008, 187:489-494.
-
(2008)
Behav Brain Res
, vol.187
, pp. 489-494
-
-
Snigdha, S.1
Neill, J.C.2
-
51
-
-
33846001008
-
Influence of gender on working and spatial memory in the novel object recognition task in the rat
-
Sutcliffe J.S., Marshall K.M., Neill J.C. Influence of gender on working and spatial memory in the novel object recognition task in the rat. Behav Brain Res 2007, 177:117-125.
-
(2007)
Behav Brain Res
, vol.177
, pp. 117-125
-
-
Sutcliffe, J.S.1
Marshall, K.M.2
Neill, J.C.3
-
52
-
-
54249140917
-
Oestradiol attenuates the cognitive deficit induced by acute phencyclidine treatment in mature female hooded-Lister rats
-
Sutcliffe J.S., Rhaman F., Marshall K.M., Neill J.C. Oestradiol attenuates the cognitive deficit induced by acute phencyclidine treatment in mature female hooded-Lister rats. J Psychopharmacol 2008, 22:918-922.
-
(2008)
J Psychopharmacol
, vol.22
, pp. 918-922
-
-
Sutcliffe, J.S.1
Rhaman, F.2
Marshall, K.M.3
Neill, J.C.4
-
53
-
-
59449098923
-
Asenapine restores cognitive flexibility in rats with medial prefrontal cortex lesions
-
Tait D.S., Marston H.M., Shahid M., Brown V.J. Asenapine restores cognitive flexibility in rats with medial prefrontal cortex lesions. Psychopharmacology (Berlin) 2009, 202:295-306.
-
(2009)
Psychopharmacology (Berlin)
, vol.202
, pp. 295-306
-
-
Tait, D.S.1
Marston, H.M.2
Shahid, M.3
Brown, V.J.4
-
54
-
-
66049164000
-
Asenapine induces differential regional effects on serotonin receptor subtypes
-
[Epub ahead of print]
-
Tarazi F.I., Moran-Gates T., Wong E.H., Henry B., Shahid M. Asenapine induces differential regional effects on serotonin receptor subtypes. J Psychopharmacol 2008, [Epub ahead of print].
-
(2008)
J Psychopharmacol
-
-
Tarazi, F.I.1
Moran-Gates, T.2
Wong, E.H.3
Henry, B.4
Shahid, M.5
-
55
-
-
43049098484
-
Differential regional and dose-related effects of asenapine on dopamine receptor subtypes
-
Tarazi F.I., Moran-Gates T., Wong E.H., Henry B., Shahid M. Differential regional and dose-related effects of asenapine on dopamine receptor subtypes. Psychopharmacology (Berlin) 2008, 198:103-111.
-
(2008)
Psychopharmacology (Berlin)
, vol.198
, pp. 103-111
-
-
Tarazi, F.I.1
Moran-Gates, T.2
Wong, E.H.3
Henry, B.4
Shahid, M.5
-
56
-
-
26444518328
-
SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit
-
Terranova J.P., Chabot C., Barnouin M.C., Perrault G., Depoortere R., Griebel G., et al. SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit. Psychopharmacology (Berlin) 2005, 181:134-144.
-
(2005)
Psychopharmacology (Berlin)
, vol.181
, pp. 134-144
-
-
Terranova, J.P.1
Chabot, C.2
Barnouin, M.C.3
Perrault, G.4
Depoortere, R.5
Griebel, G.6
-
57
-
-
0041737724
-
Comparison of the effects of antipsychotics on a delayed radial maze task in the rat
-
Wolff M.C., Leander J.D. Comparison of the effects of antipsychotics on a delayed radial maze task in the rat. Psychopharmacology (Berlin) 2003, 168:410-416.
-
(2003)
Psychopharmacology (Berlin)
, vol.168
, pp. 410-416
-
-
Wolff, M.C.1
Leander, J.D.2
-
58
-
-
77955274149
-
-
Lu AE58054, a 5-HT6 antagonist with pro cognitive potential. Int J Neuropsychopharm 2010, in press.
-
Arnt J, Bang-Andersen B, Grayson B, Bymaster FP, Cohen ML, DeLapp NW, Giethlen B, Kreilgaard M, McKinzie DL, Neill JC, Nelson DL, Møller Nielsen S, Nøhr Poulsen M, Schaus JM, Witten LM. Lu AE58054, a 5-HT6 antagonist with pro cognitive potential. Int J Neuropsychopharm 2010, in press.
-
-
-
Arnt, J.1
Bang-Andersen, B.2
Grayson, B.3
Bymaster, F.P.4
Cohen, M.L.5
DeLapp, N.W.6
Giethlen, B.7
Kreilgaard, M.8
McKinzie, D.L.9
Neill, J.C.10
Nelson, D.L.11
Møller Nielsen, S.12
Nøhr Poulsen, M.13
Schaus, J.M.14
Witten, L.M.15
|